Solid tumors display different levels of immune cell infiltration, and the presence of CD8+ T cells at the tumor site has been correlated with better overall survival (OS) and an improved response to checkpoint inhibitors in several cancer types (5–7). This evidence concerns the gene CD8A and cancer.